Request for Covid-19 Impact Assessment of this Report
The United States Angiopoietin 1 Receptor market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Angiopoietin 1 Receptor market, reaching US$ million by the year 2028. As for the Europe Angiopoietin 1 Receptor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Angiopoietin 1 Receptor players cover Aerpio Therapeutics, Inc., Deciphera Pharmaceuticals, LLC, Eddingpharm, and Exelixis, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Angiopoietin 1 Receptor market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
MAN-01
PMC-001
AP-185
ARP-1536
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Bladder Cancer
Neuroendocrine Tumors
Ovarian Cancer
Ureter Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Aerpio Therapeutics, Inc.
Deciphera Pharmaceuticals, LLC
Eddingpharm
Exelixis, Inc.
Pfizer Inc.
PharmAbcine, Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Angiopoietin 1 Receptor Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Angiopoietin 1 Receptor by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Angiopoietin 1 Receptor by Country/Region, 2017, 2022 & 2028
2.2 Angiopoietin 1 Receptor Segment by Type
2.2.1 MAN-01
2.2.2 PMC-001
2.2.3 AP-185
2.2.4 ARP-1536
2.2.5 Others
2.3 Angiopoietin 1 Receptor Sales by Type
2.3.1 Global Angiopoietin 1 Receptor Sales Market Share by Type (2017-2022)
2.3.2 Global Angiopoietin 1 Receptor Revenue and Market Share by Type (2017-2022)
2.3.3 Global Angiopoietin 1 Receptor Sale Price by Type (2017-2022)
2.4 Angiopoietin 1 Receptor Segment by Application
2.4.1 Bladder Cancer
2.4.2 Neuroendocrine Tumors
2.4.3 Ovarian Cancer
2.4.4 Ureter Cancer
2.4.5 Others
2.5 Angiopoietin 1 Receptor Sales by Application
2.5.1 Global Angiopoietin 1 Receptor Sale Market Share by Application (2017-2022)
2.5.2 Global Angiopoietin 1 Receptor Revenue and Market Share by Application (2017-2022)
2.5.3 Global Angiopoietin 1 Receptor Sale Price by Application (2017-2022)
3 Global Angiopoietin 1 Receptor by Company
3.1 Global Angiopoietin 1 Receptor Breakdown Data by Company
3.1.1 Global Angiopoietin 1 Receptor Annual Sales by Company (2020-2022)
3.1.2 Global Angiopoietin 1 Receptor Sales Market Share by Company (2020-2022)
3.2 Global Angiopoietin 1 Receptor Annual Revenue by Company (2020-2022)
3.2.1 Global Angiopoietin 1 Receptor Revenue by Company (2020-2022)
3.2.2 Global Angiopoietin 1 Receptor Revenue Market Share by Company (2020-2022)
3.3 Global Angiopoietin 1 Receptor Sale Price by Company
3.4 Key Manufacturers Angiopoietin 1 Receptor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Angiopoietin 1 Receptor Product Location Distribution
3.4.2 Players Angiopoietin 1 Receptor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Angiopoietin 1 Receptor by Geographic Region
4.1 World Historic Angiopoietin 1 Receptor Market Size by Geographic Region (2017-2022)
4.1.1 Global Angiopoietin 1 Receptor Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Angiopoietin 1 Receptor Annual Revenue by Geographic Region
4.2 World Historic Angiopoietin 1 Receptor Market Size by Country/Region (2017-2022)
4.2.1 Global Angiopoietin 1 Receptor Annual Sales by Country/Region (2017-2022)
4.2.2 Global Angiopoietin 1 Receptor Annual Revenue by Country/Region
4.3 Americas Angiopoietin 1 Receptor Sales Growth
4.4 APAC Angiopoietin 1 Receptor Sales Growth
4.5 Europe Angiopoietin 1 Receptor Sales Growth
4.6 Middle East & Africa Angiopoietin 1 Receptor Sales Growth
5 Americas
5.1 Americas Angiopoietin 1 Receptor Sales by Country
5.1.1 Americas Angiopoietin 1 Receptor Sales by Country (2017-2022)
5.1.2 Americas Angiopoietin 1 Receptor Revenue by Country (2017-2022)
5.2 Americas Angiopoietin 1 Receptor Sales by Type
5.3 Americas Angiopoietin 1 Receptor Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angiopoietin 1 Receptor Sales by Region
6.1.1 APAC Angiopoietin 1 Receptor Sales by Region (2017-2022)
6.1.2 APAC Angiopoietin 1 Receptor Revenue by Region (2017-2022)
6.2 APAC Angiopoietin 1 Receptor Sales by Type
6.3 APAC Angiopoietin 1 Receptor Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Angiopoietin 1 Receptor by Country
7.1.1 Europe Angiopoietin 1 Receptor Sales by Country (2017-2022)
7.1.2 Europe Angiopoietin 1 Receptor Revenue by Country (2017-2022)
7.2 Europe Angiopoietin 1 Receptor Sales by Type
7.3 Europe Angiopoietin 1 Receptor Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Angiopoietin 1 Receptor by Country
8.1.1 Middle East & Africa Angiopoietin 1 Receptor Sales by Country (2017-2022)
8.1.2 Middle East & Africa Angiopoietin 1 Receptor Revenue by Country (2017-2022)
8.2 Middle East & Africa Angiopoietin 1 Receptor Sales by Type
8.3 Middle East & Africa Angiopoietin 1 Receptor Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Angiopoietin 1 Receptor
10.3 Manufacturing Process Analysis of Angiopoietin 1 Receptor
10.4 Industry Chain Structure of Angiopoietin 1 Receptor
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Angiopoietin 1 Receptor Distributors
11.3 Angiopoietin 1 Receptor Customer
12 World Forecast Review for Angiopoietin 1 Receptor by Geographic Region
12.1 Global Angiopoietin 1 Receptor Market Size Forecast by Region
12.1.1 Global Angiopoietin 1 Receptor Forecast by Region (2023-2028)
12.1.2 Global Angiopoietin 1 Receptor Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Angiopoietin 1 Receptor Forecast by Type
12.7 Global Angiopoietin 1 Receptor Forecast by Application
13 Key Players Analysis
13.1 Aerpio Therapeutics, Inc.
13.1.1 Aerpio Therapeutics, Inc. Company Information
13.1.2 Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Product Offered
13.1.3 Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Aerpio Therapeutics, Inc. Main Business Overview
13.1.5 Aerpio Therapeutics, Inc. Latest Developments
13.2 Deciphera Pharmaceuticals, LLC
13.2.1 Deciphera Pharmaceuticals, LLC Company Information
13.2.2 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Product Offered
13.2.3 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Deciphera Pharmaceuticals, LLC Main Business Overview
13.2.5 Deciphera Pharmaceuticals, LLC Latest Developments
13.3 Eddingpharm
13.3.1 Eddingpharm Company Information
13.3.2 Eddingpharm Angiopoietin 1 Receptor Product Offered
13.3.3 Eddingpharm Angiopoietin 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eddingpharm Main Business Overview
13.3.5 Eddingpharm Latest Developments
13.4 Exelixis, Inc.
13.4.1 Exelixis, Inc. Company Information
13.4.2 Exelixis, Inc. Angiopoietin 1 Receptor Product Offered
13.4.3 Exelixis, Inc. Angiopoietin 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Exelixis, Inc. Main Business Overview
13.4.5 Exelixis, Inc. Latest Developments
13.5 Pfizer Inc.
13.5.1 Pfizer Inc. Company Information
13.5.2 Pfizer Inc. Angiopoietin 1 Receptor Product Offered
13.5.3 Pfizer Inc. Angiopoietin 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Inc. Main Business Overview
13.5.5 Pfizer Inc. Latest Developments
13.6 PharmAbcine, Inc.
13.6.1 PharmAbcine, Inc. Company Information
13.6.2 PharmAbcine, Inc. Angiopoietin 1 Receptor Product Offered
13.6.3 PharmAbcine, Inc. Angiopoietin 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 PharmAbcine, Inc. Main Business Overview
13.6.5 PharmAbcine, Inc. Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Angiopoietin 1 Receptor Product Offered
13.7.3 Sanofi Angiopoietin 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Teva Pharmaceutical Industries Ltd.
13.8.1 Teva Pharmaceutical Industries Ltd. Company Information
13.8.2 Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Product Offered
13.8.3 Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.8.5 Teva Pharmaceutical Industries Ltd. Latest Developments
14 Research Findings and Conclusion
Table 1. Angiopoietin 1 Receptor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Angiopoietin 1 Receptor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of MAN-01
Table 4. Major Players of PMC-001
Table 5. Major Players of AP-185
Table 6. Major Players of ARP-1536
Table 7. Major Players of Others
Table 8. Global Angiopoietin 1 Receptor Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Angiopoietin 1 Receptor Sales Market Share by Type (2017-2022)
Table 10. Global Angiopoietin 1 Receptor Revenue by Type (2017-2022) & ($ million)
Table 11. Global Angiopoietin 1 Receptor Revenue Market Share by Type (2017-2022)
Table 12. Global Angiopoietin 1 Receptor Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Angiopoietin 1 Receptor Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Angiopoietin 1 Receptor Sales Market Share by Application (2017-2022)
Table 15. Global Angiopoietin 1 Receptor Revenue by Application (2017-2022)
Table 16. Global Angiopoietin 1 Receptor Revenue Market Share by Application (2017-2022)
Table 17. Global Angiopoietin 1 Receptor Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Angiopoietin 1 Receptor Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Angiopoietin 1 Receptor Sales Market Share by Company (2020-2022)
Table 20. Global Angiopoietin 1 Receptor Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Angiopoietin 1 Receptor Revenue Market Share by Company (2020-2022)
Table 22. Global Angiopoietin 1 Receptor Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Angiopoietin 1 Receptor Producing Area Distribution and Sales Area
Table 24. Players Angiopoietin 1 Receptor Products Offered
Table 25. Angiopoietin 1 Receptor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Angiopoietin 1 Receptor Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Angiopoietin 1 Receptor Sales Market Share Geographic Region (2017-2022)
Table 30. Global Angiopoietin 1 Receptor Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Angiopoietin 1 Receptor Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Angiopoietin 1 Receptor Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Angiopoietin 1 Receptor Sales Market Share by Country/Region (2017-2022)
Table 34. Global Angiopoietin 1 Receptor Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Angiopoietin 1 Receptor Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Angiopoietin 1 Receptor Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Angiopoietin 1 Receptor Sales Market Share by Country (2017-2022)
Table 38. Americas Angiopoietin 1 Receptor Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Angiopoietin 1 Receptor Revenue Market Share by Country (2017-2022)
Table 40. Americas Angiopoietin 1 Receptor Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Angiopoietin 1 Receptor Sales Market Share by Type (2017-2022)
Table 42. Americas Angiopoietin 1 Receptor Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Angiopoietin 1 Receptor Sales Market Share by Application (2017-2022)
Table 44. APAC Angiopoietin 1 Receptor Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Angiopoietin 1 Receptor Sales Market Share by Region (2017-2022)
Table 46. APAC Angiopoietin 1 Receptor Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Angiopoietin 1 Receptor Revenue Market Share by Region (2017-2022)
Table 48. APAC Angiopoietin 1 Receptor Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Angiopoietin 1 Receptor Sales Market Share by Type (2017-2022)
Table 50. APAC Angiopoietin 1 Receptor Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Angiopoietin 1 Receptor Sales Market Share by Application (2017-2022)
Table 52. Europe Angiopoietin 1 Receptor Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Angiopoietin 1 Receptor Sales Market Share by Country (2017-2022)
Table 54. Europe Angiopoietin 1 Receptor Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Angiopoietin 1 Receptor Revenue Market Share by Country (2017-2022)
Table 56. Europe Angiopoietin 1 Receptor Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Angiopoietin 1 Receptor Sales Market Share by Type (2017-2022)
Table 58. Europe Angiopoietin 1 Receptor Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Angiopoietin 1 Receptor Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Angiopoietin 1 Receptor Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Angiopoietin 1 Receptor Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Angiopoietin 1 Receptor Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Angiopoietin 1 Receptor Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Angiopoietin 1 Receptor Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Angiopoietin 1 Receptor Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Angiopoietin 1 Receptor Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Angiopoietin 1 Receptor Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Angiopoietin 1 Receptor
Table 69. Key Market Challenges & Risks of Angiopoietin 1 Receptor
Table 70. Key Industry Trends of Angiopoietin 1 Receptor
Table 71. Angiopoietin 1 Receptor Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Angiopoietin 1 Receptor Distributors List
Table 74. Angiopoietin 1 Receptor Customer List
Table 75. Global Angiopoietin 1 Receptor Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Angiopoietin 1 Receptor Sales Market Forecast by Region
Table 77. Global Angiopoietin 1 Receptor Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Angiopoietin 1 Receptor Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Angiopoietin 1 Receptor Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Angiopoietin 1 Receptor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Angiopoietin 1 Receptor Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Angiopoietin 1 Receptor Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Angiopoietin 1 Receptor Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Angiopoietin 1 Receptor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Angiopoietin 1 Receptor Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Angiopoietin 1 Receptor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Angiopoietin 1 Receptor Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Angiopoietin 1 Receptor Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Angiopoietin 1 Receptor Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Angiopoietin 1 Receptor Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Angiopoietin 1 Receptor Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Angiopoietin 1 Receptor Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Angiopoietin 1 Receptor Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Angiopoietin 1 Receptor Revenue Market Share Forecast by Application (2023-2028)
Table 95. Aerpio Therapeutics, Inc. Basic Information, Angiopoietin 1 Receptor Manufacturing Base, Sales Area and Its Competitors
Table 96. Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Product Offered
Table 97. Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Aerpio Therapeutics, Inc. Main Business
Table 99. Aerpio Therapeutics, Inc. Latest Developments
Table 100. Deciphera Pharmaceuticals, LLC Basic Information, Angiopoietin 1 Receptor Manufacturing Base, Sales Area and Its Competitors
Table 101. Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Product Offered
Table 102. Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Deciphera Pharmaceuticals, LLC Main Business
Table 104. Deciphera Pharmaceuticals, LLC Latest Developments
Table 105. Eddingpharm Basic Information, Angiopoietin 1 Receptor Manufacturing Base, Sales Area and Its Competitors
Table 106. Eddingpharm Angiopoietin 1 Receptor Product Offered
Table 107. Eddingpharm Angiopoietin 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Eddingpharm Main Business
Table 109. Eddingpharm Latest Developments
Table 110. Exelixis, Inc. Basic Information, Angiopoietin 1 Receptor Manufacturing Base, Sales Area and Its Competitors
Table 111. Exelixis, Inc. Angiopoietin 1 Receptor Product Offered
Table 112. Exelixis, Inc. Angiopoietin 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Exelixis, Inc. Main Business
Table 114. Exelixis, Inc. Latest Developments
Table 115. Pfizer Inc. Basic Information, Angiopoietin 1 Receptor Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Inc. Angiopoietin 1 Receptor Product Offered
Table 117. Pfizer Inc. Angiopoietin 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Pfizer Inc. Main Business
Table 119. Pfizer Inc. Latest Developments
Table 120. PharmAbcine, Inc. Basic Information, Angiopoietin 1 Receptor Manufacturing Base, Sales Area and Its Competitors
Table 121. PharmAbcine, Inc. Angiopoietin 1 Receptor Product Offered
Table 122. PharmAbcine, Inc. Angiopoietin 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. PharmAbcine, Inc. Main Business
Table 124. PharmAbcine, Inc. Latest Developments
Table 125. Sanofi Basic Information, Angiopoietin 1 Receptor Manufacturing Base, Sales Area and Its Competitors
Table 126. Sanofi Angiopoietin 1 Receptor Product Offered
Table 127. Sanofi Angiopoietin 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Sanofi Main Business
Table 129. Sanofi Latest Developments
Table 130. Teva Pharmaceutical Industries Ltd. Basic Information, Angiopoietin 1 Receptor Manufacturing Base, Sales Area and Its Competitors
Table 131. Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Product Offered
Table 132. Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Teva Pharmaceutical Industries Ltd. Main Business
Table 134. Teva Pharmaceutical Industries Ltd. Latest Developments
List of Figures
Figure 1. Picture of Angiopoietin 1 Receptor
Figure 2. Angiopoietin 1 Receptor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Angiopoietin 1 Receptor Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Angiopoietin 1 Receptor Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Angiopoietin 1 Receptor Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of MAN-01
Figure 10. Product Picture of PMC-001
Figure 11. Product Picture of AP-185
Figure 12. Product Picture of ARP-1536
Figure 13. Product Picture of Others
Figure 14. Global Angiopoietin 1 Receptor Sales Market Share by Type in 2021
Figure 15. Global Angiopoietin 1 Receptor Revenue Market Share by Type (2017-2022)
Figure 16. Angiopoietin 1 Receptor Consumed in Bladder Cancer
Figure 17. Global Angiopoietin 1 Receptor Market: Bladder Cancer (2017-2022) & (K Pcs)
Figure 18. Angiopoietin 1 Receptor Consumed in Neuroendocrine Tumors
Figure 19. Global Angiopoietin 1 Receptor Market: Neuroendocrine Tumors (2017-2022) & (K Pcs)
Figure 20. Angiopoietin 1 Receptor Consumed in Ovarian Cancer
Figure 21. Global Angiopoietin 1 Receptor Market: Ovarian Cancer (2017-2022) & (K Pcs)
Figure 22. Angiopoietin 1 Receptor Consumed in Ureter Cancer
Figure 23. Global Angiopoietin 1 Receptor Market: Ureter Cancer (2017-2022) & (K Pcs)
Figure 24. Angiopoietin 1 Receptor Consumed in Others
Figure 25. Global Angiopoietin 1 Receptor Market: Others (2017-2022) & (K Pcs)
Figure 26. Global Angiopoietin 1 Receptor Sales Market Share by Application (2017-2022)
Figure 27. Global Angiopoietin 1 Receptor Revenue Market Share by Application in 2021
Figure 28. Angiopoietin 1 Receptor Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Angiopoietin 1 Receptor Revenue Market Share by Company in 2021
Figure 30. Global Angiopoietin 1 Receptor Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Angiopoietin 1 Receptor Revenue Market Share by Geographic Region in 2021
Figure 32. Global Angiopoietin 1 Receptor Sales Market Share by Region (2017-2022)
Figure 33. Global Angiopoietin 1 Receptor Revenue Market Share by Country/Region in 2021
Figure 34. Americas Angiopoietin 1 Receptor Sales 2017-2022 (K Pcs)
Figure 35. Americas Angiopoietin 1 Receptor Revenue 2017-2022 ($ Millions)
Figure 36. APAC Angiopoietin 1 Receptor Sales 2017-2022 (K Pcs)
Figure 37. APAC Angiopoietin 1 Receptor Revenue 2017-2022 ($ Millions)
Figure 38. Europe Angiopoietin 1 Receptor Sales 2017-2022 (K Pcs)
Figure 39. Europe Angiopoietin 1 Receptor Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Angiopoietin 1 Receptor Sales 2017-2022 (K Pcs)
Figure 41. Middle East & Africa Angiopoietin 1 Receptor Revenue 2017-2022 ($ Millions)
Figure 42. Americas Angiopoietin 1 Receptor Sales Market Share by Country in 2021
Figure 43. Americas Angiopoietin 1 Receptor Revenue Market Share by Country in 2021
Figure 44. United States Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Angiopoietin 1 Receptor Sales Market Share by Region in 2021
Figure 49. APAC Angiopoietin 1 Receptor Revenue Market Share by Regions in 2021
Figure 50. China Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Angiopoietin 1 Receptor Sales Market Share by Country in 2021
Figure 57. Europe Angiopoietin 1 Receptor Revenue Market Share by Country in 2021
Figure 58. Germany Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Angiopoietin 1 Receptor Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Angiopoietin 1 Receptor Revenue Market Share by Country in 2021
Figure 65. Egypt Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Angiopoietin 1 Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Angiopoietin 1 Receptor in 2021
Figure 71. Manufacturing Process Analysis of Angiopoietin 1 Receptor
Figure 72. Industry Chain Structure of Angiopoietin 1 Receptor
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...